Alkynyl-coumarinyl ethers as MAO-B inhibitors

Bioorg Med Chem. 2014 Mar 15;22(6):1916-28. doi: 10.1016/j.bmc.2014.01.046. Epub 2014 Feb 8.

Abstract

In this study, alkynyl-coumarinyl ethers were developed as inhibitors of human monoamine oxidase B (MAO-B). A series of 31 new, ether-connected coumarin derivatives was synthesized via hydroxycoumarins, whose phenolic group at position 6, 7 or 8 was converted by means of the Mitsunobu reaction. The majority of the final products were produced from primary alcohols with a terminal alkyne group. The inhibitors were optimized with respect to the structure of the alkynyloxy chain and its position at the fused benzene ring as well as the residue at position 3 of the pyran-2H-one part. A hex-5-ynyloxy chain at position 7 was found to be particular advantageous. Among the 7-hex-5-ynyloxy-coumarins, the 3-methoxycarbonyl derivative 36 was characterized as a dual-acting inhibitor with IC₅₀ values of less than 10 nM towards MAO-A and MAO-B, and the 3-(4-methoxy)phenyl derivative 44 was shown to combine strong anti-MAO-B potency (IC₅₀=3.0 nM) and selectivity for MAO-B over MAO-A (selectivity >3400-fold).

Keywords: Alkynes; Coumarins; Distribution coefficients; Mitsunobu reaction; Monoamine oxidase.

MeSH terms

  • Alkynes / chemical synthesis
  • Alkynes / chemistry
  • Alkynes / pharmacology*
  • Coumarins / chemical synthesis
  • Coumarins / chemistry
  • Coumarins / pharmacology*
  • Dose-Response Relationship, Drug
  • Ethers / chemical synthesis
  • Ethers / chemistry
  • Ethers / pharmacology*
  • Humans
  • Molecular Structure
  • Monoamine Oxidase / metabolism*
  • Monoamine Oxidase Inhibitors / chemical synthesis
  • Monoamine Oxidase Inhibitors / chemistry
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Recombinant Proteins / metabolism
  • Structure-Activity Relationship

Substances

  • Alkynes
  • Coumarins
  • Ethers
  • Monoamine Oxidase Inhibitors
  • Recombinant Proteins
  • coumarin
  • Monoamine Oxidase